Posts From Janine

Janine

Janine

Janine is our editor for related stock market news. Andrew and Janine will be focusing on providing the latest trends and where the next hit could be

Moderna Expects Trial Data for COVID-19 Vaccine in November

  The shares of Moderna Inc (Nasdaq: MRNA) hogged the limelight yesterday after the biotechnology company’s CEO, Stephane Bancel, stated that by November, the company would have adequate info about the late-stage trial to conclude whether its COVID-19 vaccine provides

Read More

AstraZeneca Aims to Deliver COVID-19 Vaccine By Year-End

  AstraZeneca PLC (NYSE: AZN) has announced that before the end of this year, the company will be able to precisely reveal whether its vaccine under trial has the ability to safeguard people from COVID-19. While making the announcement, Pascal

Read More

Tesla Stock Down as Baillie Gifford Reduces Stake

  The largest external shareholder of Tesla Inc (Nasdaq: TSLA), Baillie Gifford, has trimmed its stake in the electric vehicle manufacturer due to portfolio restrictions (no stock can be greater than 10% of clients’ portfolios). The recent surge in share

Read More

Tiffany Posts Mixed Q2 Results With Comps Down 24%

  High-end jewelry chain Tiffany & Co. (NYSE: TIF) reported a mixed second quarter, with revenues failing to meet Wall Street estimates and earnings surpassing forecasts. The company’s second-quarter performance was aided by an improvement in China sales. The company

Read More

Alibaba Beats Q1 Estimates on Cloud Computing Demand

  Alibaba Group Holding Limited (Nasdaq: BABA) reported fiscal 2020 first-quarter earnings that increased from the comparable quarter last year. The company is off to a good start in the new fiscal year, with revenue and adjusted EBITDA surging 34%

Read More

Apple Aiming to Roll Out ‘Apple One’ Subscription Packs

  In an effort to increase revenue from subscription services, Apple Inc (Nasdaq: AAPL) is working to roll out a plethora of unique subscription plans that offer a combo of services in a single pack. According to Bloomberg, which first

Read More

Bristol-Myers Beat Q2 Estimates & Won Patent Case on Eliquis

  The biopharmaceutical company Bristol-Myers Squibb Co (NYSE: BMY) swung to a loss in the fiscal 2020 second-quarter, compared with a profit in the similar period last year. However, the Q2 non-GAAP earnings were higher than last year. Furthermore, the

Read More

P&G Beats Q4 Earnings View, Issues Strong FY 2021 Outlook

  Procter & Gamble Co (NYSE: PG) reported a swing to profit in the fourth quarter and comfortably exceeded Wall Street analyst’s estimates. The company also issued a robust FY 2020 outlook on the expectation of an increase in demand

Read More

Tesla Posts Unanticipated 4th Successive Quarter Of Profits

  Shares of Tesla Motors Inc. (Nasdaq: TSLA) hogged the limelight yesterday after the electric car manufacturer posted a surprise profit for the fiscal 2020 second quarter, while analysts anticipated the automaker to report a loss. With four consecutive quarters

Read More

JNJ beats Q2 Earnings and Upwardly Revises FY 2020 Outlook

  Consumer, pharmaceutical and bio-medical devices company Johnson & Johnson (NYSE: JNJ) reported fiscal 2020 second-quarter profits that declined from last year. However, the company’s Q2 results were higher than the Wall Street estimates. Interestingly, when most of the listed

Read More